KPMA to oppose extended patent terms.

In the 5th Korea and U. S. FTA meeting on Dec. 4 the KPMA made it clear not to accept the U. S. request for the extended patent terms and its scope.

The KPMA claimed that the Korean regulatory should notify it to the patent owners for the patented products approved in the overseas with exceptional application. The conditional approval should be specified in 4 different classification of AND...